DnB Asset Management
CRSP icon

DnB Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

DnB Asset Management’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,815
Closed -$555K – 736
2024
Q3 		$555K Buy
+11,815
New +$555K ﹤0.01% 656